GB0922354D0 - Novel polymer conjugates - Google Patents

Novel polymer conjugates

Info

Publication number
GB0922354D0
GB0922354D0 GBGB0922354.6A GB0922354A GB0922354D0 GB 0922354 D0 GB0922354 D0 GB 0922354D0 GB 0922354 A GB0922354 A GB 0922354A GB 0922354 D0 GB0922354 D0 GB 0922354D0
Authority
GB
United Kingdom
Prior art keywords
polymer conjugates
novel polymer
novel
conjugates
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0922354.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abzena UK Ltd
Original Assignee
Polytherics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polytherics Ltd filed Critical Polytherics Ltd
Priority to GBGB0922354.6A priority Critical patent/GB0922354D0/en
Publication of GB0922354D0 publication Critical patent/GB0922354D0/en
Priority to EP10707337.1A priority patent/EP2403538B1/en
Priority to US13/254,003 priority patent/US9005598B2/en
Priority to PCT/GB2010/000393 priority patent/WO2010100430A1/en
Priority to PCT/GB2010/001633 priority patent/WO2011077067A1/en
Priority to US14/659,598 priority patent/US9415115B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0922354.6A 2009-03-04 2009-12-21 Novel polymer conjugates Ceased GB0922354D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0922354.6A GB0922354D0 (en) 2009-12-21 2009-12-21 Novel polymer conjugates
EP10707337.1A EP2403538B1 (en) 2009-03-04 2010-03-04 Conjugated proteins and peptides
US13/254,003 US9005598B2 (en) 2009-03-04 2010-03-04 Conjugated proteins and peptides
PCT/GB2010/000393 WO2010100430A1 (en) 2009-03-04 2010-03-04 Conjugated proteins and peptides
PCT/GB2010/001633 WO2011077067A1 (en) 2009-12-21 2010-08-27 Polymer conjugates of non-glycosylated erythropoietin
US14/659,598 US9415115B2 (en) 2009-03-04 2015-03-16 Conjugated proteins and peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0922354.6A GB0922354D0 (en) 2009-12-21 2009-12-21 Novel polymer conjugates

Publications (1)

Publication Number Publication Date
GB0922354D0 true GB0922354D0 (en) 2010-02-03

Family

ID=41717347

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0922354.6A Ceased GB0922354D0 (en) 2009-03-04 2009-12-21 Novel polymer conjugates

Country Status (2)

Country Link
GB (1) GB0922354D0 (en)
WO (1) WO2011077067A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9650331B2 (en) * 2012-06-18 2017-05-16 Polytherics Limited Conjugation reagents
JP2017534612A (en) 2014-10-14 2017-11-24 ポリセリックス・リミテッド Method for conjugation of peptides or proteins using a reagent comprising a leaving group including a PEG moiety
JP6612860B2 (en) * 2014-10-24 2019-11-27 ポリセリックス・リミテッド Conjugates and conjugate reagents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323048C (en) 1998-03-12 2006-10-10 Shearwater Polymers, Inc. Poly(ethylene glycol) derivatives with proximal reactive groups
JP2002531089A (en) * 1998-11-30 2002-09-24 イーライ・リリー・アンド・カンパニー Erythropoietic compounds
PE20010288A1 (en) 1999-07-02 2001-03-07 Hoffmann La Roche ERYTHROPOYETIN DERIVATIVES
EP1333036B1 (en) 2000-10-16 2009-01-21 Chugai Seiyaku Kabushiki Kaisha Peg-modified erythropoietin
KR100401296B1 (en) 2000-12-27 2003-10-11 드림바이오젠 주식회사 Protein Muteins Modified By Modifying Materials And Method For Producing The Same
AU2003246486A1 (en) * 2002-07-19 2004-02-09 Cangene Corporation Pegylated erythropoietic compounds
GB0316294D0 (en) 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
WO2006061853A2 (en) 2004-12-10 2006-06-15 Serum Institute Of India Limited Novel erythropoietic compounds and a process for producing erythropoietic compounds
US7714114B2 (en) 2005-02-16 2010-05-11 Nektar Therapeutics Conjugates of an EPO moiety and a polymer
EP2209494B1 (en) 2007-10-09 2016-07-20 Polytherics Limited Novel conjugated proteins and peptides

Also Published As

Publication number Publication date
WO2011077067A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
IL286056B1 (en) Conjugation methods
IL216719A0 (en) Pure-peg-lipid conjugates
PT3254678T (en) Multifunctional zwitterionic polymer conjugates
IL217881A0 (en) Polymer compositions
SI2318050T1 (en) Factor viii polymer conjugates
IL211180B (en) Peg-docetaxel conjugates
IL213794A0 (en) Novel uses
ZA201201213B (en) Polymer/thermoplastic starch compositions
EP2411440A4 (en) Improved biodegradable polymers
PL2516478T3 (en) Modified polymer compositions
PL2516474T3 (en) Modified polymer compositions
ZA201109437B (en) Novel azabicyclohexanes
ZA201105535B (en) Novel tricyanoborates
ZA201202047B (en) A polymer support
PT2398854T (en) Improved polymer preparation
GB2483195B (en) Novel uses
GB0922354D0 (en) Novel polymer conjugates
GB0906023D0 (en) Insulin-Nanoparticle conjugates
GB0908053D0 (en) Novel polymers
IT1398857B1 (en) FOSPHOLIPID POLYMERIC CONJUGATES
PL2509593T3 (en) Protein-polymer conjugates
GB0922419D0 (en) Polymer Composition
GB0914692D0 (en) Cross-link polymers
GB0910413D0 (en) Polymerization
GB0904353D0 (en) Novel thiazolopyrimidines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)